Table S1. correlation DLCO, lung volumes, cellularity of the BAL, walk distance at 1 year and all PET parameters measured at baseline. (DOCX 25Â kb
Respiratory parameters and cough during wakefulness and sleep. Table S2. Respiratory parameters, exe...
Comparison of baseline characteristics of patients with and without available QoL data (total enroll...
Circulating fibrocyte numbers in patients with IPF and idiopathic pulmonary hypertension (IPAH). (A)...
Figure S2. Correlation SUVmean-corr and delta SaO2 post exercise between baseline value and after 1 ...
Supplemental data for quantitative analysis of dynamic 18F-FDG PET/CT for measurement of lung inflam...
Characteristics of patients and the healthy subjects used for experiments. Data are mean ± standard ...
Background :Idiopathic Pulmonary Fibrosis (IPF) is a progressive and irreversible disease leading to...
Appendix - Functional respiratory imaging (FRI) methodology. Detailed description of the FRI methodo...
Figure S1. PET parameters were calculated (SUVmean, SUVmax, metabolic lung volume -MLV, total lung g...
Table S1. Quality of life scores at each follow-up visit and change in quality of life over the 3-ye...
Abstract Background Idiopathic Pulmonary Fibrosis (IPF) is a progressive and irreversible disease le...
Table S4. Sociodemographic and clinical parameters of the study sample comparing patients who were n...
Discussion guide: Living with IPF and an exploration of Esbriet® – a new treatment (1 h). (DOCX 21 k...
Locally Weighted Scatterplot Smoothing curves for FVC% predicted. a. Mild physiological impairment (...
Additional file 1: Figure S1. Relationship of FVC and DLCO with Fat-Free mass index and Frailty cate...
Respiratory parameters and cough during wakefulness and sleep. Table S2. Respiratory parameters, exe...
Comparison of baseline characteristics of patients with and without available QoL data (total enroll...
Circulating fibrocyte numbers in patients with IPF and idiopathic pulmonary hypertension (IPAH). (A)...
Figure S2. Correlation SUVmean-corr and delta SaO2 post exercise between baseline value and after 1 ...
Supplemental data for quantitative analysis of dynamic 18F-FDG PET/CT for measurement of lung inflam...
Characteristics of patients and the healthy subjects used for experiments. Data are mean ± standard ...
Background :Idiopathic Pulmonary Fibrosis (IPF) is a progressive and irreversible disease leading to...
Appendix - Functional respiratory imaging (FRI) methodology. Detailed description of the FRI methodo...
Figure S1. PET parameters were calculated (SUVmean, SUVmax, metabolic lung volume -MLV, total lung g...
Table S1. Quality of life scores at each follow-up visit and change in quality of life over the 3-ye...
Abstract Background Idiopathic Pulmonary Fibrosis (IPF) is a progressive and irreversible disease le...
Table S4. Sociodemographic and clinical parameters of the study sample comparing patients who were n...
Discussion guide: Living with IPF and an exploration of Esbriet® – a new treatment (1 h). (DOCX 21 k...
Locally Weighted Scatterplot Smoothing curves for FVC% predicted. a. Mild physiological impairment (...
Additional file 1: Figure S1. Relationship of FVC and DLCO with Fat-Free mass index and Frailty cate...
Respiratory parameters and cough during wakefulness and sleep. Table S2. Respiratory parameters, exe...
Comparison of baseline characteristics of patients with and without available QoL data (total enroll...
Circulating fibrocyte numbers in patients with IPF and idiopathic pulmonary hypertension (IPAH). (A)...
DOI
Add to ORKG